Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Honeywell International (HON -0.70%)
Q1 2021 Earnings Call
Apr 23, 2021, 8:30 a.m. ET

Contents:

  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:


Operator

Ladies and gentlemen, please stand by. Good day, and welcome to the Honeywell's first-quarter earnings release. [Operator instructions] As a reminder, this conference is being recorded. I would now like to introduce your host for today's conference, Mark Bendza, vice president of investor relations.

Please go ahead, sir.

Mark Bendza -- Vice President of Investor Relations

Thank you, Jake. Good morning, and welcome to Honeywell's first-quarter 2021 earnings conference call. On the call with me today are chairman and CEO, Darius Adamczyk; and senior vice president and chief financial officer, Greg Lewis. This call and webcast, including any non-GAAP reconciliations, are available on our website at www.honeywell.com/investor.

Note that elements of this presentation contain forward-looking statements that are based on our best view of the world and of our businesses as we see them today. Those elements can change based on many factors, including changing economic and business conditions, and we ask that you interpret them in that light. We identify the principal risks and uncertainties that may affect our performance in our annual report on Form 10-K and other SEC filings. This morning, we will review our financial results for the first quarter of 2021, share our guidance for the second quarter, and provide an update to our full-year 2021 outlook.

10 stocks we like better than Honeywell International
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* 

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Honeywell International wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of February 24, 2021

As always, we'll leave time for your questions at the end. With that, I'll turn the call over to chairman and CEO, Darius Adamczyk.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you, Mark, and good morning, everyone. Let's begin on Slide 2. We delivered a very strong start to 2021, exceeding the high end of our first-quarter organic sales growth, segment margin, and adjusted earnings per share guidance range. In the first quarter, we delivered adjusted earnings per share of $1.92, down 13% year over year and $0.09 above the high end of our guidance range.

Organic sales were down 2% year over year, a 5-percentage-point sequential improvement from the 7% organic sales decline in the fourth quarter of 2020. We drove year-over-year organic sales growth in two out of our four segments, HBT and SPS, despite facing difficult comps since the first quarter of 2020 wasn't fully impacted by the pandemic. Honeywell Building Technologies returned to growth, and safety and productivity solutions achieved an outstanding 47% organic growth in the quarter. We also drove double-digit year-over-year organic growth in connected software sales, driven by strong demand for our connected buildings and cyber solutions.

We delivered segment margin of 21%, 10 basis points above our guidance, with margin expansion in aerospace, HBT, and SPS. We generated $757 million of free cash flow in the quarter, a strong performance despite increased investments in high-return capital expenditures, which were up approximately $80 million year over year as we position ourselves for the recovery. Adjusted free cash flow conversion was 56%, up 500 basis points year over year on the strength of working capital improvements. In terms of capital, we deployed $3 billion to dividends, growth capex, share repurchases, and M&A during the quarter.

We opportunistically repurchased 4 million shares throughout the quarter, reducing our share count to 705 million. We're off to a strong start in 2021. And I'm very confident the continued improvement in our end markets, coupled with accelerated innovation and strong execution, will provide a long runway for continued business improvement and top-tier value creation for our shareholders. Next, let's turn to Slide 3 to discuss a few of our recent business highlights.

I'm excited to share a few recent recognitions and partnerships that highlight our commitment to upholding the highest ethical standards and our focus on creating breakthrough innovations. First, Honeywell is one of only eight companies in the industrial manufacturing category to be named one of the World's Most Ethical Companies by Ethisphere. Ethisphere is an organization that evaluates and honors businesses around the globe and across industries for their strong cultural, environmental, social, governance, and diversity practices. We are proud to have earned this prestigious ranking.

Second, Honeywell was named to Fast Company's annual list of the World's Most Innovative Companies for '21. In addition to being recognized for a 100-year heritage of creating groundbreaking technologies like quantum computing that transform the way the world works, Honeywell was also recognized for mobilizing quickly to help people and businesses cope with the pandemic, including our launch of new N95 mask manufacturing and our introduction of UV treatment systems for airplanes, healthy building solutions, and innovative Aclar Edge bottles and vials. We also recently announced our partnership with musician and entrepreneur, will.i.am, to launch the XuperMask, a one-of-a-kind, innovative, smart face mask for the mid- and post-pandemic world. The XuperMask is easily adjustable to fit a variety of face shapes and is enhanced with multiple functions for the modern lifestyle, including dual three-speed fans and HEPA filters for enhanced breathability, active noise-cancelling audio and microphone capabilities, and Bluetooth connectivity.

Finally, we're continuously evaluating our portfolio for M&A opportunities that can enhance our existing offerings. During the first quarter, we signed an agreement to acquire a majority stake in Fiplex Communications, a company that develops in-building communication systems, including bidirectional amplifiers that provide continuous and critical in-building radio coverage in challenging environments to improve the safety of first responders and building occupants. The addition of Fiplex products and software enhance our offering in the fast-growing in-building communication market and complement our innovative, industry-leading portfolio, enabling us toward creating the next generation of fire and life-safety solutions. Now, let me turn it over to Greg on Slide 4 to discuss our first-quarter results in more detail and to provide an update on our 2021 outlook.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Thank you, and good morning, everyone. As Darius highlighted, we're very pleased with our start to 2021. While the COVID pandemic continues to impact some of our end markets, our laser focus on demand generation, operational execution, and cost management enabled us to over-deliver on our commitments. First-quarter sales declined by 2% organically due to the effects of the COVID-19 pandemic, which represents a 5-percentage-point sequential improvement from the fourth quarter.

As Darius mentioned, that was driven by robust double-digit growth in our warehouse automation solutions and personal protective equipment businesses, as well as continued demand for our building products and services, advanced material strength, and strength in our connected software. We expanded margins year over year in three out of four segments, aerospace, HBT, and SPS, for the second consecutive quarter, limiting Honeywell's overall segment margin contraction to 80 basis points and ending the quarter with a segment margin of 21%. Our commercial excellence and strong cost management, as well as an approximately $30 million one-time benefit in aerospace, drove 10 basis points of outperformance in segment margin compared to the high end of our guidance range despite the mix headwind from much stronger sales in our lowest-margin segment, SPS. We delivered adjusted earnings per share of $1.92, down 13% year over year.

This was $0.09 above the high end of our guidance, driven by segment profit improvement from higher sales volumes and by a lower-than-expected effective tax rate. From a year-over-year perspective, below-the-line items were an $0.11 headwind, driven by lower interest income and FX and higher repositioning and interest expense, partially offset by higher pension income. Our effective tax rate was higher than the first quarter of 2020 primarily due to benefits realized in the prior-year period from tax law changes in India and the resolution of certain U.S. tax matters, driving a $0.13 headwind.

This was partially offset by a $0.03 EPS benefit from lower share count. A bridge of all this from 1Q '20 to 1Q '21 adjusted EPS can be found in the appendix of this presentation. We generated $978 million of cash from operations, up 4% year over year despite lower net income. Free cash flow for the quarter was $757 million, down 5% year over year due to higher capital expenditures, particularly in SPS, as we continue to expand PPE capacity.

Working capital improvements, including strong collections, offset these headwinds during the quarter, driving adjusted free cash flow conversion of 56%, up 500 basis points from the prior year. As you know, the first quarter is historically our lowest from a cash perspective, and we remain on track to our full-year cash guidance. I'll talk more about our full-year outlook in a few minutes. We strategically deployed $3 billion to M&A, share repurchases, dividends, and capex in the first quarter, which significantly exceeded our operating cash flow.

We paid $640 million in dividends; deployed approximately $220 million in capex, up 60%; repurchased over $820 million of Honeywell shares, reducing our share count to 705 million; and also, we completed the purchase of Sparta Systems, deploying a total of $1.3 billion to further bolster our software, controls, and analytics capabilities in the attractive life sciences space. The integration of Sparta is progressing well. And in fact, we exceeded our first-quarter financial expectations, with sales of Sparta up 25% year over year and bookings up approximately 75% year over year. In March, we also repaid $800 million in maturing senior notes as we began the process to repay debt taken on to provide incremental liquidity during the COVID-19 pandemic.

We maintained a strong balance of cash, cash equivalents, and short-term investments at the end of the first quarter of $12.7 billion. So all in all, we had a very strong start to 2021. We are investing for the future, continuing to execute commercially and operationally with the discipline and rigor you have come to expect from Honeywell, positioning ourselves well for the recovery ahead. Now, let's turn to Slide 5 and talk about the individual segment results.

Starting with aerospace, first-quarter sales were down 22% organically, driven by lower commercial aerospace demand due to the ongoing impact of reduced flight hours and lower original equipment volumes. Our air transport aftermarket sales were down 48% organically year over year and down 7% sequentially from 4Q '20 as rising infection rates, the pace of vaccinations early in the quarter, and the lack of the peak holiday travel contributed to flight hour declines as we messaged was possible in 4Q. Our business aviation aftermarket sales were down only 6% organically year over year as we see a faster recovery in this space. In original equipment, while still down year over year, our business aviation OE grew double digits sequentially from 4Q '20, driving a 6% sequential growth in the total commercial original equipment from 4Q.

Defense and space was down 2% organically as demand for U.S. defense and space was offset by lower international defense volumes. Aerospace segment margin expanded 110 basis points to 29%, driven by strong cost management in the face of organic sales declines and an approximate $30 million one-time benefit. Building Technologies returned to growth in 1Q despite facing the most difficult comps we'll see this year since 1Q '20 was only partially impacted by the pandemic.

Sales were up 2% organically, driven by demand for building management systems and security and commercial fire products, as well as continued growth in building solutions services. Orders and backlog for building solutions services were both up double digits year over year, positioning the business for continued growth in '21. In addition, our portfolio of healthy building solutions maintained strong customer momentum with exciting wins with the Jacksonville Jaguars, the Pittsburgh Airport, and Syracuse University. HBT segment margins expanded 200 basis points to 22.5%, driven by commercial excellence and productivity, net of inflation.

PMT sales were down 47% -- excuse me, were down 6% organically, a six percentage point sequential improvement from the 12% organic sales decline we saw in 4Q. Process solutions sales were down 9% organically driven by continued project delays and lower smart energy demand due to some softness in the end markets, partially offset by demand for field instruments. Orders for services, process measurement, and control products, and thermal solutions grew in the quarter, positioning the HPS service and products businesses for acceleration in the second quarter and beyond. And UOP, sales were down 14% organically, driven by the ongoing weakness in the energy end markets.

However, this was a 16-point sequential improvement from the 30% organic decline we saw in 4Q. UOP orders were up double digits driven by gas process and catalyst orders, so we are seeing some signs of growth potential for the future. Finally, advanced materials sales increased 8% year over year organically driven by growth broadly across the portfolio, including strong growth in fluorine products, specialty additives, chemicals, and electronics materials demand. PMT segment margins contracted 290 basis points in the first quarter, driven by the impact of sales mix, partially offset by commercial excellence and cost management.

Finally, in safety and productivity solutions, sales were up 47% organically, as Darius mentioned earlier, driven by strength across the portfolio, including double-digit organic growth in warehouse and workflow solutions, personal protective equipment, and productivity solutions and services, who drove market share gains due to strong demand in the U.S. and Europe. SPS orders were up double digits year over year for the sixth straight quarter driven by continued demand for personal protective equipment and productivity solutions and services. SPS backlog was up approximately 70% year over year, remaining above $4 billion for the third consecutive quarter, including $2.1 billion of backlog for warehouse and workflow solutions.

SPS segment margins expanded 180 points in the first quarter due to -- to 14.3% driven by the impact of those higher sales volumes. So overall, we finished the first quarter with a return to sales growth in HBT and with continued growth in other areas of the portfolio, as well as backlog strength in HBT, warehouse and workflow solutions, productivity solutions and services, PPE, and UOP. We expanded margins in three of the four segments, while strategically investing in high-return growth capex and R&D, giving us confidence that our businesses are well positioned as demand recovers. With that, let's turn to Slide 6 and discuss our preview for the second quarter.

As the timing and speed of the economic recovery continues to unfold, we entered the second quarter well positioned with strong momentum and some key areas of the portfolio continuing to make progress each quarter. For the second quarter, we expect organic growth in the range of 10% to 13% as we lap the first full quarter disrupted by the COVID-19 pandemic. We expect some of the areas in the portfolio that have been most significantly impacted, particularly the commercial aerospace aftermarket and HPS businesses to return to growth. We also expect ongoing strength in safety and productivity solutions, building products, and advanced materials.

We would normally see a seasonal step-up from 1Q to 2Q, which this year will be somewhat dampened by the calendar impact of having more days in the first quarter than we do in 2Q. We will be facing some supply chain constraints as the sourcing environment for direct materials and components such as semiconductors and resins continues to be challenging. We have taken swift actions to partner with our distributors to mitigate those impacts, but our second-quarter sales will be somewhat constrained as these shortages create higher lead times, primarily in SPS and, to a lesser extent, in HBT. As a reminder, during 2020, we responded fast and early to the pandemic by identifying and delivering on a two-phase program that reduced our fixed cost base by $1.5 billion, and approximately 70% of these savings, or about $1 billion, were permanent reductions.

As such, we'll see approximately $500 million of headwind in 2021 for the year from the temporary savings measures we implemented and as we resume some areas of spending, including business travel, merit increases, and investments in growth, particularly in R&D. These impacts will begin to accelerate in 2Q, though we are confident our streamlined cost base gives us ample capacity to invest and positions us well to drive margin expansion across all four segments as sales recover. We expect sales -- excuse me, we expect segment margin in the range of 19.8% to 20.3% for the second quarter, which represents 130 to 180 basis points of margin expansion year over year. From a sequential perspective, our second-quarter segment margin expectations do result in contraction from the first quarter due to the mix impact of higher sales from lower-margin businesses, higher research and development expenses as we invest back into the business, particularly aerospace, and the cost impacts that I mentioned earlier, as well as the first-quarter benefit in aerospace, which won't repeat.

The net below-the-line impact, which is the difference between segment profit and income before tax, is expected to be flat to a $55 million benefit, with a range of repositioning between $50 million and $100 million for the quarter as we continue to fund ongoing restructuring projects. We expect the effective tax rate to be in the range of 23% to 24% for the quarter, and our average share count should be flat to 1Q at approximately 705 million shares. As a result, we expect second-quarter earnings per share between $1.86 and $1.96, up 48% to 56% year on year. Now let's take a moment just to talk through the segments.

In aerospace, we expect flight hours to improve in the second quarter, driving sequential and year-over-year improvement in commercial aftermarket sales as domestic travel improves. That will be tempered by ongoing softness in international travel as flight hours remain far below pre-COVID levels there. We still expect a slow ramp in commercial original equipment build rates. Moderate U.S.

defense spending should continue in the second quarter, though this will be pressured by low international defense volumes. In building technologies, as business conditions improve and as the world prepares to safely return to offices, schools, and to travel, we expect continued demand for building products and management systems, as well as sequential and year-over-year building solutions growth as we execute our projects and services backlog. In addition, we expect continued customer demand for our portfolio of healthy building solutions, which we began converting into sales in the first quarter. In PMT, we expect continued recovery in the process solutions products businesses, as well as sequential improvement in automation projects.

While UOP orders were up double digits year over year in the first quarter, as I mentioned earlier, we expect customer capex and opex budgets to remain tight in 2Q, limiting the delivery and execution of those opportunities in the near term. We expect continued strength in advanced materials in the second quarter driven by growth across the portfolio, particularly by strong demand for foreign products. Finally, we anticipate continued strength in SPS with another quarter of robust double-digit organic growth in warehouse and workflow solutions, personal protective equipment, and productivity solutions and services. Our warehouse and workflow solutions backlog remains strong, over $2 billion as I mentioned previously, as customers make investments in advance of the busy holiday season, giving us confidence in continued growth.

Our PPE and productivity solutions and services backlogs are both up triple digits, which will drive growth in the second quarter though as I mentioned, we will be managing some supply constraints here. Overall, we expect another strong quarter for SPS. So with that foundation for 2Q, let's turn to Slide 7 and talk about the key changes to our 2021 outlook since the guidance we provided in January. Over the past few months, we've seen tremendous progress in the distribution administration of the COVID-19 vaccine, particularly in the U.S., the U.K., and the Middle East, coupled with improvements in infection rates in many of those geographic areas.

We're also encouraged by talks of fiscal stimulus that will further support economic growth, including funding for infrastructure, clean energy, and manufacturing investments. While the pace of recovery varies regionally with slower vaccine rollouts in India, Europe, and Latin America, and with the emergence of new COVID-19 variants, we will continue to navigate the recovery with a balanced approach of investment and cost management in order to drive value longer term. So let's take a moment to walk through what's changed since our prior guidance. Starting in aerospace, we continue to expect gradual improvement in our commercial aerospace business as the pandemic subsides.

The business aviation aftermarket is on track to recover as expected and perhaps at a somewhat faster pace than we thought. And air transport, the aftermarket business had a slow start to the year as I mentioned earlier, being down sequentially compared to the fourth quarter as virus outbreaks and challenges with vaccine rollouts tempered improvements in the first-quarter flight hours. The pace of this acceleration will vary regionally, with domestic travel clearly recovering faster than international travel. And country-by-country dynamics will make this difficult to predict.

We remain cautious in our ramp expectations here as this unfolds. We continue to see moderate demand for U.S. defense and space, offset by lower-than-expected international defense volumes. As a result of these dynamics, we expect organic growth for the year in aerospace to trend toward the low end of our flat to low single-digit guidance, which we provided in January, and overall, aerospace segment margin expansion to be somewhat impacted by the slower ramp and high-margin commercial aftermarket sales.

In HBT, we still expect organic sales growth to be up low single digits for the year. The business is seeing robust activity and is trending toward the upper end of the low single-digit range, with continued demand for building products, and management systems, and continued momentum in healthy building solutions fueling that growth. We continue to expect segment margin expansion driven by higher sales on a streamlined cost base. In PMT, our expectations have not changed materially from our initial guidance.

We still expect organic sales growth to be slightly -- to be down slightly to up low single digits for the year. The recovery is progressing with strength in advanced materials and improvement in process solutions products and a slower recovery in HPS projects and UOP catalysts as customer spending has not materially changed, delaying projects and reloads, which contributes to our view that we are trending toward the low end of this -- at this time. We continue to expect sequential segment margin expansion throughout the year in PMT driven by cost management and some improved mix from UOP in the second half, though the specific timing of that remains uncertain. The recovery in oil and gas looks to be building momentum for a stronger 2022.

Finally, in SPS, warehouse and workflow solutions, PPE, and productivity solutions and services are all trending better than expected in January. We now expect higher double-digit organic sales growth than in our previous guidance as short-cycle sales accelerated in productivity solutions and services and will be accelerating in our sensor businesses, though that will be somewhat tempered by the supply tightness I mentioned earlier. The increase in warehouse automation sales, which are lower margin as you know, will impact our overall SPS segment margins, though this will be partially offset by increased sales in the higher-margin PPE and productivity solutions businesses. Now let's turn to Slide 8 and talk about our updated guidance for the year.

Given the macro and segment backdrop I just talked about, our strong outperformance in the first quarter, and our confidence in our ability to deliver through the economic recovery, we are raising our full-year sales, earnings per share, and free cash flow guidance. We now expect sales of $34.0 billion to $34.8 billion, which represents overall organic sales growth in the range of 3% to 5%, an increase of two points in the low end and one point on the high end compared to our previous guidance. Given that our strengthening sales outlook is heavily driven by our lower-margin SPS segment, we are maintaining our segment profit guidance in the range of 20.7% to 21.1%, an expansion of 30 to 70 basis points for the year. We still expect margin expansion in all of our segments as we carefully invest back into the business while managing the multispeed recovery across the portfolio.

We do not expect material changes to our net below-the-line impact at this time, which we estimate to be in the range of negative $130 million to a positive $20 million for the year, including capacity for $400 million to $525 million of repositioning. We continue to expect a full-year effective tax rate of approximately 21% to 22%, and a weighted average share count of approximately 705 million for the year, representing our minimum 1% reduction in shares. As a result, we're raising the low end of our adjusted earnings per share guidance and now expect a range of $7.75 to $8, up 9% to 13%. This represents an increase of $0.15 in the low end, effectively increasing the midpoint of our guidance by approximately $0.08.

We expect free cash flow in the range of $5.2 billion to $5.5 billion, which is higher than the low end of our previous guide by $100 million. So overall, a great start to the year and a meaningful upgrade to our full-year view and sales, segment profit, cash, and ultimately, adjusted EPS as we manage the initial stages of this recovery. So with that, I'll turn the call back over to Darius.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you, Greg. Before we wrap up, I'd like to take a minute on Slide 8 to discuss ESG. At Honeywell, we consistently say and firmly believe that a robust environmental, social, and governments framework enable us -- enables us a long-term success. In fact, responsible corporate citizenship is an essential part of our value creation framework.

Importantly, we announced a commitment earlier this month to become carbon neutral in our operations and facilities by 2035. This represents a continuation of our ongoing sustainability efforts which have already reduced the greenhouse gas intensity of our operations and facilities by more than 90% since 2004. In addition, we worked extensively to increase energy efficiency, conserve water, minimize waste, and proactively champion responsible remediation projects that restore valuable community assets. We plan to achieve our commitment through a combination of further investments in energy savings projects, conversion to renewable energy sources, completion of capital improvement projects at our sites and in our fleet of company vehicles, and utilization of credible carbon credits.

We have decades-long history of innovating to help customers meet their environmental and social goals. In fact, about half of Honeywell's new product introduction in research and development investment is directed toward products that improve environmental and social outcomes for customers. For example, the widespread adoption of Honeywell's Solstice line of low global warming potential refrigerants, blowing agents, and aerosols has already reduced the equivalent of more than 200 million metric tons of carbon dioxide to date, equal to eliminating the emissions from more than 42 million cars. A few days ago, we announced that Whole Foods Market has adapted the solti -- Solstice N40 lower global warming potential refrigerant in more than 100 of U.S.

stores as it seeks to reduce refrigerant emissions under the U.S. Environmental Protection Agency's GreenChill program. This is just one example of how our innovative products and services continue to improve customer sustainability profiles and how Honeywell is playing an active role in shaping a future that is safer and more sustainable for generations to come. Now, let's wrap up on Slide 10.

In summary, we delivered a strong start to 2021 with first-quarter results that exceeded expectations. We're seeing promising signs of rapid recovery in some of our markets and we're executing in our rigorous and proven value creation framework, which consistently delivers shareholder outperformance in all economic cycles and will continue to enable us to return to our key long-term growth commitments in 2021 and beyond. With that, Mark, let's move to Q&A.

Mark Bendza -- Vice President of Investor Relations

Thank you, Darius. Darius and Greg are now available to answer your questions. We ask that you please be mindful of others in the queue by asking only one question. Jake, please open the line for Q&A.

Questions & Answers:


Operator

[Operator instructions] We will begin with Steve Tusa with J.P. Morgan.

Steve Tusa -- J.P. Morgan -- Analyst

Hey, guys. Good morning.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Good morning.

Steve Tusa -- J.P. Morgan -- Analyst

I'll ask my one question in five parts. On the -- on -- on -- on the second quarter, you guys had said in the last call that margins would kind of, you know, build from 1Q to 2Q, even excluding the $30 million in aero. They're down. First of all, kind of what changed relative to what you were expecting back then? And then second of all, just in kind of the -- the second half of the year, you know, normally, things kind of level out from the second quarter.

Is this you're going to be a little bit different seasonally given the later cycle nature of -- of the company? And then last one would be on aerospace. How -- how do you think your performance compared to like what you gauge as flight hours, you know, this -- this quarter on your -- on your aftermarket?

Darius Adamczyk -- Chairman and Chief Executive Officer

That was almost five, but I think you've got to four.

Steve Tusa -- J.P. Morgan -- Analyst

Three -- three.

Darius Adamczyk -- Chairman and Chief Executive Officer

So let's start with the mar -- margins. On the margins, the -- the biggest thing that changes is the -- the mix makeup of our Q2. And sort of the -- the fastest growing business for us is Intelligrated, which was going to be growing even faster than we anticipated, and it -- you know, think about sort of a mid to high double-digit growth rate for that business. So we -- our bookings, our success, our output is growing, and frankly, it's mixing in at even more as part of the overall portfolio.

So that -- that is the number one and primary reason that, you know, there is a little bit of that change. You know, some of the headwinds, merits, those things, that we anticipated that, so there is really no change in that. But, you know, the -- the short answer is the Intelligrated business is growing even faster than we anticipated and continues to -- to be a growth engine for us. You know, in terms of the second half, I -- I think the one thing to -- to be -- to be -- to interpret it wrongly for our earnings releases that were somehow less bullish on the second half.

We're not. We're actually very excited about the second half. And -- but frankly, it's one quarter in in a year where there are many, many unknowns, including COVID rates, in terms of infection rates, and current supply chain and so on. You know, we don't see anything in there that we're particularly worried about.

But it is one quarter into a year which probably has many more unknowns than most. I think your third question was around sort of what's up, what's down. I would say -- I would characterize the following in terms of, you know, our -- our BGA flight hours are actually up vis-a-vis our initial assumptions. So that's what's up.

What's down is our air transport, which obviously is a bigger number vis-a-vis BGA. So, you know, in total, we're about the same but -- but, you know, it's -- it's a little bit different. And then lastly, I would tell you that, you know, defense and space was, you know, roughly where we expected. You know, the U.S.

markets were strong, the internationals were a little bit weaker. You know, we're sort of looking at that for the rest of the year. We don't know if there was some sort of channel loading that kind of happened at the end of the year, not that we drove it, but the distributors themselves. So -- so those are sort of the puts and takes.

But, you know, the -- the framework that -- that everybody ought to just full -- fully understand is we are very bullish on our markets, and what we're seeing is the short cycle is coming back very strongly compared --all -- you also add on that Intelligrated. I mean, when was the last time, Steve, you've seen any segment in any of our peers grow 47% year over year. I mean, that's remarkable. And now, in the sec -- whether it's in the third or fourth quarter of this year, you're going to see some of our longer-cycle businesses coming back, whether it's PMT and aerospace.

I can't exactly call it whether that's Q3 or Q4. There's a lot of moving pieces. But they're going to come back. And as you well know, those are higher-margin businesses.

So we're-- you know, I think we're on a really, really nice ramp here coming up for our future. Greg, I don't if you're going to add to that.

Greg Lewis -- Senior Vice President and Chief Financial Officer

No, I think you -- I think you hit it right on and -- and, you know, I think we've positioned ourselves well for what's to come. You know, you -- you mentioned some of the temporary costs that we talked about coming back and they will be coming back starting in 2Q. You know, merits go in in April. So -- so these are -- these are things that -- and we're going to increase our investment in R&D as we said.

So I think you hit the -- the salient points.

Steve Tusa -- J.P. Morgan -- Analyst

Thanks. Just FYI, pool pumps grew 50% this quarter, so they -- they beat you guys on that front. Pentair pool pumps, just letting you know. Thanks.

Darius Adamczyk -- Chairman and Chief Executive Officer

Pool pumps. It was pretty close there, Steve, 47 to 50, you know.

Operator

We'll now take our next question and that will come from Scott Davis with Melius Research. Please go ahead.

Scott Davis -- Melius Research -- Analyst

Good morning, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Good morning.

Scott Davis -- Melius Research -- Analyst

Do I -- do I read your answer to me that you're going to enter the pool pump business?

Darius Adamczyk -- Chairman and Chief Executive Officer

Apparently, it's an opportunity. We need to go investigate.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Yeah, I think there's an opportunity.

Scott Davis -- Melius Research -- Analyst

I'm going to keep it simple. Can you just talk about price broadly versus cost?

Darius Adamczyk -- Chairman and Chief Executive Officer

Sure. Yeah. No. Yeah, that's -- that's -- that's definitely a watch-out item for -- for the year.

And for us, inflation is -- is taking hold. That -- there's no doubt about it. We knew it. We see it.

It's real. And if you don't stay on top of it, the two areas where -- and this is not a surprise, steel, semiconductors, copper, ethylene. Those are the four elements that we saw substantial inflation in -- in Q1. I can tell you that we stood up a pricing team, which has been in place since the beginning of the year.

We're quickly taking actions. And, you know, we are staying ahead of it. And we're going to continue to model when that happens and stay ahead of it. But it's a watch-out item.

I don't think things are going to abate. You know, the short cycle is definitely hot. We also read the same articles around semiconductors and what's going on there, and -- and I think we're going to have to just stay ahead of it. But, you know, we do expect an inflationary environment this year and we're going to stay ahead of it.

That's our commitment.

Scott Davis -- Melius Research -- Analyst

OK. I'll pass it on. Thank you, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thanks, Scott.

Operator

We'll now hear from Julian Mitchell with Barclays.

Julian Mitchell -- Barclays Investment Bank -- Analyst

Hi, morning. Maybe just sticking to the one-question rule. The SPS margin outlook. Maybe just give us some context short and long term.

I think you said Q2, the margins, you know, are probably worse. So maybe, you know, how mu -- how large is that sequential step down in SPS? And also longer term, you know, you've got that close to 20% guide out there. What's the approximate sort of aspiration of when people should think about that, or is it just sort of off the table for the medium term because of how good the growth is?

Greg Lewis -- Senior Vice President and Chief Financial Officer

Yes. So, Julian, I -- I don't think we said that margins contract in SPS sequentially. I think what we were trying to highlight is simply it's at -- at, you know, in the 14s, it's the lowest one in the portfolio, and it's driving the -- the biggest part of the growth. So it gives, you know, some pressure to the overall margin expansion for -- for Honeywell.

I think we're going to see margins, you know, improve modestly for -- for SPS during the course of the year. Because even for -- for Intelligrated is an example. We're going to have our peak quarter most likely here in Q2 on the revenue side. And then that will start to advance a little bit as -- as the year progresses as well.

You -- you know that that business can be very lumpy on the install. That's not new news. So the movement of that will -- will influence the, you know, the margin progression. As it relates to your 20% target.

We absolutely still have that in mind in -- in the longer term. It's -- it's probably not, you know, 24 months from now. You know, we -- we've talked quite a bit about the, you know, trying to -- to capture the install base, particularly in -- in the warehouse segment, and the -- the whole point of that has been to follow with a terrific service and aftermarket business with software attached. And so, you know, as and when that -- that shift occurs, then we'll see, you know, those margins mixing up.

And then again, with the recovery that we've had in places like PSS, you know, which I think Kevin Dehoff and -- and the team there have done a terrific job in that business, we start seeing margin accretion again in there. So you know, we still have very much a --a line of sight to that 20% but with, you know, roughly maybe even close to a $3-billion business in -- in -- in the warehouse this year at the lower margins, that's going to give it some short term pressure.

Darius Adamczyk -- Chairman and Chief Executive Officer

If I could just maybe add a little more color in the long term, and this is I think very, very consistent of the framework we provided. The Intelligrated business is growing at a highly dynamic range. I mean, I think, mid to high double-digit kind of range, and the mixes are down even moving the SPS portfolio. We've been, you know, that -- that's not news.

I think what is news is that we're continuing to take substantial market share in the marketplace. Building installed base and as the buildup of the warehouse infrastructure moderates, you know, we're going to get higher-margin business because, obviously, then it's got to mix -- mix much more to the LSSO. There's really no bad news here, this is actually fantastic news that we're taking share, growing extraordinarily quickly. And as I've said all along, Intelligrated has -- is the best acquisition we've ever done at Honeywell.

Now, it's more -- more or less undeniable and, oh, it's a business that continues to do well and I see it -- I see it being primarily a projects business for mix, you know, short to mid-term because the demand is still very, very high, whether it's North America and Europe, and we're going to capture that share. Ultimately, that's going to become our higher margin business as it becomes a bit more installed base-centric.

Julian Mitchell -- Barclays Investment Bank -- Analyst

That's great. Thank you.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Greg Lewis -- Senior Vice President and Chief Financial Officer

You bet.

Operator

Next up we have Nicole DeBlase with Deutsche Bank.

Nicole DeBlase -- Deutsche Bank -- Analyst

Yeah, thanks. Good morning, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Good morning, Nicole.

Nicole DeBlase -- Deutsche Bank -- Analyst

So maybe I -- I wanted to focus a little bit on HBT. I know you -- that's part of, you know, the whole margin mix-down dynamic for the year. But HBT margin continues to move higher and a lot better than we had expected this quarter. I guess, how do you think about the sustainability at this strong incremental that you saw there in the first quarter? If you could kind of talk about the Q1 dynamics as well as how you see margins progressing throughout the rest of the year in our business?

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah, no. We're -- we're very, you know, we're very bullish on the HBT business. The healthy buildings offering has kicked in. As you know, we booked roughly $100 million of that business in -- in the year 2000.

We expect it to be several hundred million in the year 2021. We're -- as we look at the Biden infrastructure plan, there's a substantial amount of money something to the tune of $50 billion for particularly education and infrastructure. We think that they are going to be able to play in there. The team has done a great job managing the margin profile in the mix.

So -- so you know, we -- we can -- we're very bullish on what's going to happen on HBT and -- and we think we're -- we're very constructive on it for the rest of the year.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Yeah. And I -- I would just say the, you know, as you mentioned, very strong margins in the first quarter, 22.5%. Our long-term target in this business was 23%. So this is one, you know, this is the beauty of a portfolio, you don't get everyone exactly the same time but this -- this is one that's trending toward the high end.

You know, some of that is -- is going to be a little bit abated in the second half and perhaps even in the second quarter as the -- as the project's business, you know, becomes a bit bigger in the mix. So -- but we feel very good about the progress that that team has made overall and over the last 18, 24 months post the spin of the home's business. I think they've done a terrific job on productivity, on footprint, new product introductions. So I -- I really think with them on that team have been doing is -- is quite good.

And you know, they're -- they're approaching -- they're approaching their, you know, their long-term target here as we -- as we roll through 2021.

Nicole DeBlase -- Deutsche Bank -- Analyst

Got it. Thanks, I'll pass it on.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Operator

We'll now hear from Deane Dray with RBC Capital Markets.

Deane Dray -- RBC Capital Markets -- Analyst

Thank you. Good morning, everyone.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Good morning, Deane.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Deane Dray -- RBC Capital Markets -- Analyst

Hey, I would love to get some color on Sparta. That -- those are pretty heady numbers sales up 25%, bookings up 75%. Just give us a sense of what's the normalized run rate? What are the applications in it? It's kind of reminiscent of the way Intelligrated started and that turned out to be pretty sustainable in terms of double digits. So just that level status here if you could, please.

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah, no. Good -- good question and we're very, very happy with the start in Sparta. And you know, sometimes, when you acquire a business you kind of hold your breath until you actually own it. And so did we -- did we buy what we thought we bought.

And -- and I'm very, very happy to report that we're very excited about the business. We've bought exactly what we thought we're going to buy. You know, that the first quarter numbers speak for themselves in strong double-digit growth. Bookings that are sort of multiples of that, you know, being in the life sciences space and providing quality management solutions is I think going to have a very, very long runway for the future.

We've got a great team in place there, we've augmented the team with some professionals as well, and we're extraordinarily well-positioned to make that a big winner, and then drive the synergies of our Honeywell Process Solutions business. I mean, we -- we forget that that business is now really growing that a life sciences segment of the business at a disproportionate rate. This will be a further catalyst to enable even more growth. And by the way, it's substantially margined accretive too.

So you know, it wasn't -- it wasn't kind of -- it wasn't maybe the typical Honeywell acquisition that we make but we feel very, very good about it. And now, I'm kind of being the proud owner for about a quarter and it all looks good for Q2 and the rest of the year as well.

Deane Dray -- RBC Capital Markets -- Analyst

Great thanks. I'll pass it on.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Operator

Moving on to Jeff Sprague with Vertical Research.

Jeff Sprague -- Vertical Research Partners-- Analyst

Good morning, everyone.

Darius Adamczyk -- Chairman and Chief Executive Officer

Jeff, good morning.

Jeff Sprague -- Vertical Research Partners-- Analyst

Morning. We'll keep an eye on Sparta. But for now, the second-best acquisition Honeywell ever did was you UOP. I wonder if we could talk about that a little bit more.

And really that kind of the nature of my question is very interesting that we see the backlog pick up, right? We're seeing this high level of activity in the chem space, in particular, that's probably pushing out turnarounds. But maybe, you could just give us a little bit more color on how you see the year playing there, how the business, you know, might kind of mix? And you know, if there's any kind of related commentary in HPS as part of that answer that would certainly be interesting.

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah, yeah. Sure. Well, you know, I think there were certainly some encouraging signs in Q1. I mean, you know, we had double-digit bookings in yell -- there -- their services -- their catalyst part of the business is coming back in our sort of book-to-bill is -- in much better shape this year than, you know, versus our assumptions this year versus where it was last year, so that's also promising signs.

You know, we're seeing some activity come back. And I also want to highlight maybe a very important part of that portfolio for our future, which is the sustainability technology solutions business. Its quote log is in the $100 million range now and growing very very quickly. Its bookings were up 25% and if we're talking to literally tens of different energy producers today about our sustainability technology solutions portfolio, which is highly expansive.

I mean. from plastics recycler ability. to eco finding. to energy storage.

to hybrid -- to hydrogen energy, to carbon capture, we have all these solutions. So I am very optimistic about that business and it may look very different three to four years from now than it does today because we've overinvested into our sustainability technology solutions for products. Now, on the larger projects and -- and you know this, you know, sort of the opex, capex budgets, you know, I sort of expect that although I wouldn't view the price of oil and gas to be very friendly toward investment. You know, we think that that still could be a couple of quarters away just because of where the budgets were set for a lot of the majors.

And you know, as you know, they were depressed for this year. However, they are investing in the refurbishment, the catalyst, and so on. And if you look at -- and lastly on your question as it relates to HPS, if you look at the HPS-UOP cycle, HPS typically trails UOP by two to four quarters. That's sort of mathematically help has worked.

So you know, we -- we -- we see some encouraging signs and those signs are going to get better and the business is going to get better for the next several quarters. So we're, you know, we're going to be patient but we're very confident and this environment is going to keep improving because, as you know, you have to reinvest. And although we're moving to more non-carbon energy infrastructure, we're still going to need carbon for a while. And so we've got two different growth factors, number one is to sustain the current but also to help those businesses transition to the future.

Jeff Sprague -- Vertical Research Partners-- Analyst

Maybe just a brief follow on Darius, are you seeing any of those large kinds of transportation fuel to petrochemical projects kind of coming back on the board?

Darius Adamczyk -- Chairman and Chief Executive Officer

We're seeing some activity in some discussions because, as you know, that's exactly right, which is, you know, a greater switch from, you know, fuels to petrochemicals. So that's very much a part of our -- that kinds of discussions and -- and -- and quote log that we're having. So you know, frankly, some of the projects are not being released yet, they're being delayed but we're highly, highly confident those will happen.

Jeff Sprague -- Vertical Research Partners-- Analyst

Right. Thank you.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Operator

Now, we will we'll hear from Peter Arment with Baird.

Peter Arment -- Robert W. Baird -- Analyst

Hey, good morning, Darius, Greg.

Darius Adamczyk -- Chairman and Chief Executive Officer

Hey, Peter. Good morning.

Peter Arment -- Robert W. Baird -- Analyst

If there's -- the question is more on a kind of regional basis, just particularly focused on Europe. You know, we'd -- we'd look at first quarter flight activity in general, and domestically we were -- in the U.S. we were down 32% but we were down 62% in Europe. I guess, the question is really how are you looking at Europe today just more broadly speaking not just aerospace across your businesses? How you're seeing the recovery there? Thanks.

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah, no. I mean, you know, Europe probably was a bit slower than we anticipate in terms of flight hours. I mean, that -- that's clear in Q1. And Europe, I mean, I think there's a -- there's a direct correlation toward vaccinations, right? And then we kind of -- as we look at Europe, they're probably, you know, let's call it three to six months behind the U.S.

in terms of the vaccination rates. So we're going to kind of continue to see the slow rate of recovery here as we move through the year and we actually do expect a fairly robust domestic flight market in the U.S. It probably won't be the case in Europe but we think that that's probably going to push back into the fall. But you know, Europe, you know, sort of that the leaders are U.K., U.S., Israel, UAE.

Those are -- those markets are recovering fairly quickly. You know, I think Europe will be next. You know, China is in a pretty good place. You know, India is a bit of a trouble spot and Latin America is a bit of a trouble spot.

So those will probably be recovered late this year. Then we see a very strong pick up next -- even stronger pickup next year, particularly on the international routes. But some of those will recover in the second half of this year. I anticipate especially U.S., Middle East, Europe, U.K.

routes to be fairly active even in the second half of this year.

Peter Arment -- Robert W. Baird -- Analyst

Appreciate it. Thanks.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Thank you.

Operator

And Gautum Khanna from Cowen has the next question.

Gautum Khanna -- Cowen and Company -- Analyst

Yeah. Thanks. Good morning, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Good morning.

Gautum Khanna -- Cowen and Company -- Analyst

I was wondering if you could elaborate on -- yeah, if you could elaborate on the after -- commercial aerospace aftermarket. You mentioned, you know, sequentially it was down -- maybe you could tease out how much ROE a large commercial -- commercial ATR was down. And then what are you -- you mentioned that it will be up in Q2, what are you seeing from a bookings standpoint? What kind of indications are you getting for the magnitude of the improvement in Q2 and --and maybe your thoughts beyond that?

Greg Lewis -- Senior Vice President and Chief Financial Officer

It seems like the -- the flight hours from Q1 to Q2 want to be up in the call of 20% range. You know, whether we have a little bit of a lag to that or not, you know, remains to be seen. But you know, as you highlighted and we talked about the -- the Q4 to Q1 decrement is the lack of Thanksgiving and Christmas. You know, the January, you know, the -- the December and January, you know, infection acceleration.

So, as those things start coming down, domestic travel we expect will, you know, the -- the main beneficiary. And you see that from all the airlines who have reported, you know, Southwest, which is mostly a domestic leisure travel, is doing fantastic. And, you know, those who are reliant on -- more on the business travel are going to suffer. So, you're going to see that -- you're going to see that domestic and -- and international and business travel bifurcation.

Exactly how that's going to, you know, play out is -- is really, you know, kind of remains to be seen. And even as -- as we've mentioned earlier, with places like Europe, domestic travel in intra-Europe is -- has been depressed a little bit, given -- given the fact that they've had some additional lockdowns in -- in some of the -- some of the countries with the outbreaks there. So, it -- it really is -- it's really a country-by-country, region-by-region, you know, impact. And so, you know, putting a precise -- putting a precise finger on that is going to be a little bit elusive.

Operator

And with Citigroup, we have Andy Kaplowitz for the next question.

Andy Kaplowitz -- Citi -- Analyst

Hey, good morning, guys.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Hey, Andy.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Andy Kaplowitz -- Citi -- Analyst

Darius, you've talked about accelerating cash deployment in Q1 with the $3 billion that you allocate to high-return opportunities including Sparta. But could you update us on the M&A pipeline you're seeing? Obviously, you -- we've talked about valuations not being cheap out there, but do you think you can continue to ratchet up M&A over the next few quarters given what you see?

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah. You know, I mean, the pipeline continues to be good. You're -- you're right, the valuations are not exactly low. But, you know, we're going to, you know, we're going to be opportunistic and -- and we're going to look for kind of I would call the needles in the haystack and -- and think -- finding things that work for us, that makes sense for us, we think they exist.

And, you know, sometimes, you got to -- you have to go in places where maybe everybody else isn't running to because obviously, those things have very, very expensive price tags. And we have some ideas that I think could be pretty interesting for a portfolio. So, we -- it's a -- it's a very robust pipeline and we're always working on a couple of things that hopefully will land and anticipate, you know, we're going to be doing more deals in 2021, and then also looking at other level -- levers of capital deployment as well.

Andy Kaplowitz -- Citi -- Analyst

Thanks, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Operator

Now, we will hear from Nigel Coe with Wolfe Research.

Nigel Coe -- Wolfe Research -- Analyst

Good morning, guys.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Nigel Coe -- Wolfe Research -- Analyst

And I just -- just came back into the [Inaudible]. Just kidding.

Darius Adamczyk -- Chairman and Chief Executive Officer

Back --

Nigel Coe -- Wolfe Research -- Analyst

I did -- did want to -- I -- I -- I go back to the comments about the supply chain constraints in 2Q and I don't know if you want to, you know, try and quantify. But if -- if you look at normal seasonality, the -- the 1Q you've seen a step up that Gregg, you talked about. It seems like it might be in the range of maybe $2 million or $3 million. Is that sort of the right range? And -- and, you know, where are you seeing these constraints? Is it -- is it mainly in semi or is that -- is that broader than that? And -- and do you think 2Q is sort of paying for this and begin some semblance of normality in half of the year?

Darius Adamczyk -- Chairman and Chief Executive Officer

Yes. No, the constraints are significant and they are in semi. And by the way, just to be very clear, the constraints are reflected in our guide, OK? So so, I just want to be very clear about that. But the constraints are significant and they are -- primarily in our SPS and more specifically SPSS business.

And, you know, think about a-million-over-a-hundred-million-plus kind of a number, OK? Because -- so -- so, it's -- it's not -- it's not small, it's actually significant. We do think it will abate over the year, but Q2 is -- is challenging because, you know, frankly, the guide could have been even higher. And -- and we, you know, we are working and we've really projected an outlook for the rest of the year and we're -- we're looking for alternative source. Or actually, Torsten Pilz this year as -- as our supply chain officer.

So, I don't know if Torsten if you want to provide more color.

Torsten Pilz -- Senior Vice President and Chief Supply Chain Officer

Yeah. Yeah. I think we have two -- two areas. Semiconductors is one and resins is the other one.

We believe that the resin impact will subside by the end of Q2, but the semiconductor impact will continue throughout the year.

Nigel Coe -- Wolfe Research -- Analyst

That's the question --

Greg Lewis -- Senior Vice President and Chief Financial Officer

And as if -- that's right. Not a lot.

Darius Adamczyk -- Chairman and Chief Executive Officer

Nigel, you're breaking up. We couldn't hear your question.

Nigel Coe -- Wolfe Research -- Analyst

Also, I was saying just a push, a step on the second half or you think this is luck still.

Darius Adamczyk -- Chairman and Chief Executive Officer

I think -- I -- I don't know what you said, but I'm -- I heard loss. Is it lost sales? We think it's a push because obviously, a lot of these suppliers are -- are -- were -- were not unique. It's obviously being impacted, so it's not as if the demand is going away. So, we think that this is probably a push to the second half of the year, you know, but -- but we'll see.

It's -- we've, you know, that business has been a really, really nice success story for us. And, you know, if we go back a couple of years, maybe it wasn't such a success story. Had a terrific year last year and just further accelerated this year, and absolutely growing very, very quickly. So, you know, we're -- it's still going to have a good -- good quarter in Q2, but it could have been a phenomenal blow-out quarter in Q2.

Nigel Coe -- Wolfe Research -- Analyst

Great. Thank you very much.

Darius Adamczyk -- Chairman and Chief Executive Officer

Thank you.

Operator

Andrew Obin with Bank of America will have the next question.

Andrew Obin -- Bank of America Merrill Lynch -- Analyst

Hi, yes, good morning.

Darius Adamczyk -- Chairman and Chief Executive Officer

Good morning.

Greg Lewis -- Senior Vice President and Chief Financial Officer

Hey, Andrew.

Andrew Obin -- Bank of America Merrill Lynch -- Analyst

Yeah, I think that maybe Julian was messing with Nigel's line to keep him from asking too many questions, but who knows. It's a competitive business. Just a question on aerospace on Arrow. You know, in various sort of twisted way, we're getting a lot of questions the fact that your margin in Arrow already is so high at the bottom of the cycle.

And I was just wondering if we could take a longer-term view and if you could talk about sort of longer-term levers to keep margin expansion going in this business, both in terms of specific end-market recovery but also operating initiatives.

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah. Well, I think, you know, I think Q1 was a bit telling. And although we were very transparent about a $30 million one-timer, or even if you exclude that element, I mean, you know, that the margins were still in the upper 20s. So, I think we demonstrated the credibility of the say-do that we believe this business can be in the upper 20s.

I mean, I -- this is a case in point. And take out the $30 million and we're still in the upper 20s. So, I think that that's really important. You know, yeah, I mean, this maybe isn't a high point in sort of the investment profile of Arrow.

But I can tell you, and as Greg pointed out, we are investing in Arrow today on some of the major platforms and products. So, I would say it's an all-time low, but -- and our R&D dollars are going up from 2020 to 2021. And -- and we still expect extraordinarily, attractive margins for that business. So, you know, I -- I think that it's -- we're investing.

It's a -- it's a great business and, you know, better things are yet to come, which I think maybe gets misunderstood which is, you know, a lot of that H -- HCR aftermarkets not kicking in yet. You know, I think the BGA is going to get better. I mean -- so, we have some brighter things on the future. And even at this kind of business levels, you know, we can print something the upper 20s.

So, I -- I just think that hopefully, people start believing that this is a very good business which is going to get even better for the future. And Greg --

Greg Lewis -- Senior Vice President and Chief Financial Officer

Yeah. I -- I would just -- maybe just augment that. So, as you said, we -- we printed 29%, you take the $30 million out, it's still $28 million, you know, high 27s. You know, our long-term target that we highlighted was $27 million.

So, again, we're -- we're there on that but we're going to continue to invest. And so, you know, I think this business has -- has done a -- a very good job and it was -- obviously, that and PMT were the most impacted by the pandemic. It did a terrific job on -- on their cost management and realigning their cost structure to the size of the business, and that's coming through. But, you know, to Darius' point, we're going to make sure that we continue to invest and grow it.

We're not going to over earn, you know, and -- and print margins that are, you know, let's say, unhealthy for the long-term viability of the business.

Mark Bendza -- Vice President of Investor Relations

Jake, let's take one more question, please.

Operator

And that will -- question will come from Sheila Kahyaoglu with Jefferies.

Sheila Kahyaoglu -- Jefferies -- Analyst

Hey. Good morning, guys. Thank you.

Darius Adamczyk -- Chairman and Chief Executive Officer

Hey, Sheila. Good morning.

Sheila Kahyaoglu -- Jefferies -- Analyst

Good morning. I'll have to tell Andrew it was me messing with Nigel's line, so -- to -- to pair it up. I guess, sticking with Arrow, you mentioned commercial OE was up sequentially, business was up double digits, I think you said. Was that a surprise? What platforms drove that? And related to that, what are you expecting on commercial OE build rates as they progressed throughout the year?

Greg Lewis -- Senior Vice President and Chief Financial Officer

Yeah. So, it was definitely up sequentially as -- as highlighted. Not really unexpected. You know, we're starting to see some of the -- some of the build rates, you know, recover.

It's going to be slow from here. You know, I -- I would say the level we're at right now is going to be, you know, kind of a slow ramp from -- from this point. So, it's not like we see anything changing dramatically to the upside here, you know, imminently. So, but -- but not really unexpected for -- for what we've seen.

You see what's happening with the, you know, with the mask coming back into service, and so on. So, we -- we feel like we're, you know, we're sized properly for -- for that ramp as -- as we head into the -- the second quarter and -- and the back half of the year. On -- on BGA, certainly, you know, that aftermarket stream, it's just -- it's just going to grow at a faster pace than -- than HCR. I mean, people are shifting.

This -- this is actually a question for, you know, the -- the -- the HCR business. People are shifting from, you know, commercial travel to, you know, business jet travel. That's happening. And so, there's -- there -- there may be some element of commercial first-class travel that actually from a business perspective, you know, doesn't fully come back.

So -- so, we do feel bullish about what we're seeing in -- in the BGA space, particularly. But -- but as I said earlier, there are so many variables as -- as, you know, as well as we do. There are so many variables that go onto this between passenger behavior, airline -- airline behavior, you know, that's a little bit as to why, you know, we're going to take this one quarter at a time.

Darius Adamczyk -- Chairman and Chief Executive Officer

Yeah. And just to maybe add to that is, yeah, I -- I think what we have looking forward is our OE rate slowly increasing. And I think that that's -- we have a fairly high degree of confidence in there throughout this year, particularly second half versus the first half. And then increasing even more in 2022.

So -- so, that's sort of the math. I mean, I -- I think we also forget that, you know, as recently as three months ago, I mean, some of the infection rates in the U.S. were very, very high and we're not a dramatically different place. So -- so, the overall, you know, January and -- and part of February were fairly difficult.

But, you know, we -- we see -- we see the world slowly coming out of this and -- and it's -- if there's going to be a direct correlation to aviation. And -- and we think, you know, this is going to be manifested in the second half of this year than '22 and '23. And, you know, we're set up for some very, very nice quarters and years ahead of us, which are going to be slowly ramping up. So, I -- we continue to be very bullish on aviation, we're investing in the business.

But at the same time, you know, 2020 was a good opportunity for us to really rationalize some cost structure. And I think we can lever up nicely as that business starts coming back.

Sheila Kahyaoglu -- Jefferies -- Analyst

Great. Thank you.

Darius Adamczyk -- Chairman and Chief Executive Officer

OK. I'm -- I'm proud of everyone at Honeywell. The consistent hard work and unwavering commitment enable us to outperform in this challenging environment. Thank you to our shareholders for your ongoing support.

We are well-positioned for the recovery with a strong start to the year and I look forward to opportunities to come during the balance of 2021 and beyond. Thank you all for listening and please stay safe and healthy.

Operator

[Operator signoff]

Duration: 68 minutes

Call participants:

Mark Bendza -- Vice President of Investor Relations

Darius Adamczyk -- Chairman and Chief Executive Officer

Greg Lewis -- Senior Vice President and Chief Financial Officer

Steve Tusa -- J.P. Morgan -- Analyst

Scott Davis -- Melius Research -- Analyst

Julian Mitchell -- Barclays Investment Bank -- Analyst

Nicole DeBlase -- Deutsche Bank -- Analyst

Deane Dray -- RBC Capital Markets -- Analyst

Jeff Sprague -- Vertical Research Partners-- Analyst

Peter Arment -- Robert W. Baird -- Analyst

Gautum Khanna -- Cowen and Company -- Analyst

Andy Kaplowitz -- Citi -- Analyst

Nigel Coe -- Wolfe Research -- Analyst

Torsten Pilz -- Senior Vice President and Chief Supply Chain Officer

Andrew Obin -- Bank of America Merrill Lynch -- Analyst

Sheila Kahyaoglu -- Jefferies -- Analyst

More HON analysis

All earnings call transcripts